Cardiac Sense

Backed by a strong IP portfolio that includes developments in optics, mechanics, and signal processing, CardiacSense's unique, state-of-the-art smartwatch provides long-term, continuous, accurate, monitoring of heart arrhythmias (such as atrial fibrillation or cardiac arrest) and blood pressure. CardiacSense recently obtained FDA clearance for ECG, Oxygen Saturation (SpO2), and beat-by-beat HR. Their expert multidisciplinary team combines years of clinical, technical, and business experience.